SCHEMBL2200089

SCHEMBL2200089

Cc1ccc(NC(=O)CCN2CCOCC2)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.52
MAPK14 Q16539 2/20 0.49
MAPK13 O15264 1/20 0.49
MAPK12 P53778 1/20 0.49
MAPK11 Q15759 1/20 0.49
RAB9A P51151 1/20 0.47
TNIK Q9UKE5 1/20 0.47
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
EGFR P00533 2/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
POLB P06746 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
PAK1 Q13153 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199162 0.84 MAPK13 (0.57) MAPK14MAPK13MAPK12MAPK11RAB9A
SCHEMBL2199318 0.83 ALDH1A1 (0.51) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL2200097 0.83 MAPK13 (0.59) MAPK14MAPK13MAPK12MAPK11RAB9A
SCHEMBL2198811 0.82 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11HPGD
SCHEMBL2198486 0.82 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11RAB9A
SCHEMBL2196197 0.81 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11EGFR
SCHEMBL2855101 0.81 DDX3X (0.49) MAPK14MAPK13MAPK12MAPK11RAB9A
SCHEMBL2199640 0.80 MAPK13 (0.52) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL2198253 0.79 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11RAB9A
SCHEMBL2197746 0.79 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US claimed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 ATM 883/4885MAPK14 697/4885MAPK13 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.